FDA Approves NuvOx IND Brain Tumor Trial

18.04.2017 - The US Food and Drug Administration (FDA) has approved NuvOx Pharma’s application to proceed with Phase 2 clinical trials for an Investigational New Drug (IND) to initiate a Phase...